Op-Eds Crypto’s next fight isn’t just about regulation. It’s about who owns the names of innovation Duggan Flanakin · September 14, 2026 11:00 am
Op-Eds 92% of American corn is modified — and Big Ag is suing to keep the recipe secret Alex H. Moss · September 13, 2026 10:00 am
Op-Eds Big Pharma’s patent monopoly is stealing your next paycheck — and driving up costs David Marin, James Gelfand · September 12, 2026 7:00 am
Fairness and Justice Access to justice drives American innovation Kristen Osenga · September 5, 2026 11:00 am
Op-Eds A federal judge thinks you’re too stupid to read an ice cream label Jeffrey Lax · August 20, 2026 6:00 am
Op-Eds A hidden legal glitch is undermining Trump’s AI agenda James Edwards · August 10, 2026 10:00 am
Op-Eds People are fed up, and Trump needs affordability win. Here’s his chance Lamar Smith · June 26, 2026 8:00 am
Op-Eds GLP-1 market shows how Americans can get lower drug prices Melanie Whittington, Joshua Kresh · June 1, 2026 11:00 am
Economy Drug price relief is within reach — but only if Washington moves now James Gelfand · April 17, 2026 9:00 am
Op-Eds Big Tech’s patent battering ram isn’t lowering drug prices James Edwards · March 27, 2026 10:00 am
Fairness and Justice Trump should restore little-known patent program to help local retailers Stephanie A. Martz · March 22, 2026 8:00 am
Op-Eds
